Bj. Biemond et al., COMPLETE INHIBITION OF ENDOTOXIN-INDUCED COAGULATION ACTIVATION IN CHIMPANZEES WITH A MONOCLONAL FAB FRAGMENT AGAINST FACTOR VII VIIA/, Thrombosis and haemostasis, 73(2), 1995, pp. 223-230
Gram-negative sepsis is oftentimes complicated by activation of coagul
ation with disseminated intravascular coagulation and microthrombosis.
This may contribute to the associated morbidity, multiple organ failu
re and death. Recent studies have established that the tissue factor-d
ependent pathway of blood coagulation has a significant participatory
role in the initial endotoxin-induced activation of coagulation. Tissu
e factor (TF), expressed on the surface of activated monocytes and end
othelial cells forms cell surface complexes with free circulating fact
ors VII and VIIa. The latter complex proteolytically activates factors
X and IX. Recent in vivo experiments have shown that a rapidly neutra
lizing TF monoclonal antibody prevents and arrests the endotoxin-induc
ed activation of coagulation and similar studies have shown to reduce
mortality in baboons. In this study we describe the preparation of a f
actor VII/VIIa neutralizing monoclonal Fab fragment and characterize i
ts effect on in vivo activation of coagulation during experimental end
otoxemia in chimpanzees. Four chimpanzees received a bolus intravenous
injection of 4 ng/kg endotoxin in combination with Fab fragments of a
factor VII/VIIa neutralizing murine monoclonal antibody (12D10) at a
dose of either 50 mu g/kg (n = 2) or 100 mu g/kg (n = 2). Four control
animals received a bolus injection of endotoxin alone. Administration
of the 12D10 Fab fragments, immediately preceding the endotoxin bolus
injection, effectively blocked the endotoxin-induced activation of co
agulation. Plasma levels of products of in vivo activation, namely F12, TAT complexes and FpA remained at baseline values. The administrati
on of 12D10 resulted in a rapid decline in factor VII/VIIa antigen lev
els which remained below 5 ng/ml for 180-240 min, followed by a rapid
return to baseline levels. Endotoxin administration resulted in activa
tion of the fibrinolytic fibrinolytic system as reflected by a rapid i
ncrease in plasma plasmin-alpha(2)-antiplasmin complexes. Administrati
on of 12D10 was without effect on the endotoxin-induced fibrinolytic a
ctivation. In conclusion, this study confirmed the importance of the T
F:VII complex in the initial, endotoxin-induced activation of coagulat
ion which was completely blocked by neutralizing all free and tissue f
actor-complexed factor VII/VIIa by a specific monoclonal Fab fragment.
Activation of fibrinolysis was not influenced. Therefore, neutralizat
ion of factor VII/VIIa might be a promising therapeutic option in prev
enting endotoxin-induced microthrombosis during Gram-negative sepsis.